タンパク質チップ（プロテインチップ）の世界市場：2024-2031年

タンパク質チップ（プロテインチップ）市場は予測期間（2024-2031年）にCAGR 6.4％で成長すると予測されています。タンパク質チップは、プロテインマイクロアレイとしても知られ、プロテオミクスにおいて1回の実験で複数のタンパク質を並行して検出・定量するために使用されるハイスループット技術です。固体表面、典型的にはスライドガラスやシリコンチップで構成され、その上に抗体、ペプチド、タンパク質などの特定の捕捉分子がアレイ形式で固定化されています。タンパク質マイクロアレイ市場の成長を支える主な要因は、個別化医療や精密診断に対する需要の高まり、技術投資、イノベーションです。

市場力学

タンパク質チップ技術の進歩：プロテオミクスと診断に革命をもたらす

タンパク質チップ技術の進歩は、プロテオミクス研究と臨床診断の分野に革命をもたらしました。これらの進歩には、マイクロアレイ作製、表面化学、検出方法の改良が含まれ、タンパク質チップの感度、特異性、多重化機能の強化につながっています。高度なタンパク質チッププラットフォームは、複雑な生物学的サンプルから何千ものタンパク質を同時に分析することを可能にし、バイオマーカー探索、創薬標的同定、パスウェイ解析をかつてないスピードと精度で促進します。このような技術革新は、様々な研究開発や臨床応用に合わせた新規のタンパク質チップアッセイの開発を促進し、世界のタンパク質チップ市場の成長に拍車をかけています。例えば、2023年12月、Theralink Technologiesは、ジョージ・メイソン大学およびカリフォルニア大学サンフランシスコ校と共同で実施した画期的な調査を発表しました。ISPY-2試験を通じて、700人以上の乳がん患者の腫瘍が逆相タンパク質アレイ（RPPA）を用いて評価され、困難な乳がんに対する新たな治療手段が発見されました。

個別化医療におけるタンパク質チップの役割

個別化医療に対する需要の高まりは、世界のタンパク質チップ市場の軌道を形成する重要な要因です。個別化医療は、遺伝的体質、プロテオミクスプロファイル、環境要因など、個々の患者の特性に基づいて、オーダーメイドの治療介入を提供することを目的としています。タンパク質チップは、分子レベルでの疾患バイオマーカー、分子シグネチャー、治療反応の同定を可能にすることで、個別化医療において重要な役割を果たしています。患者サンプルのタンパク質発現パターンやシグナル伝達経路を分析することで、タンパク質チップは臨床医に、患者の治療、治療法の選択、疾病管理戦略に関して、十分な情報に基づいた決定を下す力を与えます。個別化医療がヘルスケアで注目されるにつれ、分子プロファイリングと精密診断に不可欠なツールとしてのタンパク質チップの需要は拡大し続け、市場の拡大と製品の多様化を促進しています。

市場セグメンテーション

• タイプ別では、市場は解析用マイクロアレイ、機能性タンパク質マイクロアレイ、逆相タンパク質マイクロアレイに区分されます。
• 用途別では、市場は抗体特性評価、臨床診断、プロテオミクスに区分されます。
• 最終用途別では、市場は製薬・バイオテクノロジー企業、学術・研究機関、診断研究所、病院・クリニックに区分されます。

機能性タンパク質マイクロアレイが最大セグメントとなる見込み

機能性タンパク質マイクロアレイ分野は、市場で最大のシェアを占めると予想されています。このセグメントの成長を支える主な要因は、ハイスループットタンパク質解析における汎用性と有用性です。機能性タンパク質マイクロアレイは、1回の実験で何千ものタンパク質相互作用、タンパク質間結合イベント、酵素活性、翻訳後修飾の同時スクリーニングを可能にします。このハイスループット能力により、新規タンパク質機能、バイオマーカー、創薬標的、治療化合物の発見が加速され、基礎研究、医薬品開発、臨床診断の進歩が促進されます。

臨床診断分野が大きな市場シェアを占める

臨床診断セグメントは、個別化医療と精密診断の進展に重要な役割を果たすため、かなりの市場シェアを占めています。タンパク質チップは、がん、心血管疾患、感染症、神経疾患など、さまざまな疾患を迅速かつ正確に検出するために、臨床現場でますます活用されるようになっています。タンパク質の発現パターンを分析し、疾患特異的なバイオマーカーを同定することで、臨床医は高い感度と特異性をもって、疾患の早期診断、治療効果の予測、疾患の進行のモニタリングを行うことができます。例えば、2023年11月、Octave Bioscience, Inc.はマイケル・J・フォックス財団（The Michael J. Fox Foundation）から1,000万米ドルの助成金を獲得し、パーキンソン病の多分析タンパク質バイオマーカー検査を開発し、疾患評価の向上を目指しています。

地域別展望

世界のタンパク質チップ市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。

精密医療の強化：タンパク質チップ市場におけるアジア太平洋地域の台頭

アジア太平洋地域は、いくつかの主要促進要因によって、世界のタンパク質チップ分野で最も急成長している市場として浮上しています。同地域では、経済拡大や政府のイニシアティブに後押しされ、医療インフラや研究能力への多額の投資が、タンパク質チップのような先端技術の採用を促進しています。アジア太平洋地域は、慢性疾患や感染症に罹患している多くの人々を含む、大規模で多様な人口を抱えており、タンパク質ベースの診断ソリューションのための実質的な市場を提供し、タンパク質チップの需要を煽っています。さらに、この地域では精密医療や個別化医療への注目が高まっており、国内外のプレーヤー間の協力も相まって、市場の成長をさらに後押ししています。

北米が主要市場シェアを占める

全地域の中で北米が大きなシェアを占めているのは、強固な医療インフラ、研究エコシステム、大手製薬会社が創薬や個別化医療などの用途でタンパク質チップの需要を大きく牽引しているためです。さらに、同地域はヘルスケアの革新と技術進歩に重点を置いており、政府のイニシアティブと資金援助が有利であることも、市場成長をさらに後押ししています。特に慢性疾患の患者が多い北米は、タンパク質ベースの診断ソリューションに大きなビジネスチャンスをもたらしています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主要市場動向
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Agilent Technologies, Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Bio-Rad Laboratories, Inc.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Thermo Fisher Scientific Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• タンパク質チップの世界市場：タイプ別
  • 解析用マイクロアレイ
  • 機能性タンパク質マイクロアレイ
  • 逆相タンパク質マイクロアレイ
• タンパク質チップの世界市場：用途別
  • 抗体特性評価
  • 臨床診断
  • プロテオミクス
• タンパク質チップの世界市場：最終用途別
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • 診断研究所
  • 病院・クリニック

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• Arrayit Corporation
• Biotech Support Group
• Bruker
• CapitalBio Technology Co, Ltd.
• CDI Laboratories Inc.
• Full Moon BioSystems Inc.
• GE Healthcare
• Gyros Protein Technologies
• HORIBA, Ltd.
• Illumina Inc.
• Innopsys Inc.
• Merck KGaA
• OriGene Technologies Inc.
• PerkinElmer
• Randox Laboratories Ltd.
• RayBiotech, Inc.
• Sengenics Corporation LLC
• Shimadzu Scientific Instruments
• Surmodics Inc.

LIST OF TABLES

• 1. Global Protein Chip Market Research And Analysis By Type, 2023-2031 ($ Million)
• 2. Global Analytical Microarrays Protein Chip Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Functional Protein Microarrays Protein Chip Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Reverse Phase Protein Microarrays Protein Chip Market Research And Analysis By Region, 2023-2031 ($ Million)
• 5. Global Protein Chip Market Research And Analysis By Application, 2023-2031 ($ Million)
• 6. Global Protein Chip For Antibody Characterization Market Research And Analysis By Region, 2023-2031 ($ Million)
• 7. Global Protein Chip For Clinical Diagnostics Market Research And Analysis By Region, 2023-2031 ($ Million)
• 8. Global Protein Chip For Proteomics Market Research And Analysis By Region, 2023-2031 ($ Million)
• 9. Global Protein Chip Market Research And Analysis By End-Use, 2023-2031 ($ Million)
• 10. Global Protein Chip In Pharmaceutical & Biotechnology Companies Market Research And Analysis By Region, 2023-2031 ($ Million)
• 11. Global Protein Chip In Academic & Research Institutes Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. Global Protein Chip In Diagnostic Laboratories Market Research And Analysis By Region, 2023-2031 ($ Million)
• 13. Global Protein Chip In Hospitals & Clinics Market Research And Analysis By Region, 2023-2031 ($ Million)
• 14. Global Protein Chip Market Research And Analysis By Region, 2023-2031 ($ Million)
• 15. North American Protein Chip Market Research And Analysis By Country, 2023-2031 ($ Million)
• 16. North American Protein Chip Market Research And Analysis By Type, 2023-2031 ($ Million)
• 17. North American Protein Chip Market Research And Analysis By Application, 2023-2031 ($ Million)
• 18. North American Protein Chip Market Research And Analysis By End-Use, 2023-2031 ($ Million)
• 19. European Protein Chip Market Research And Analysis By Country, 2023-2031 ($ Million)
• 20. European Protein Chip Market Research And Analysis By Type, 2023-2031 ($ Million)
• 21. European Protein Chip Market Research And Analysis By Application, 2023-2031 ($ Million)
• 22. European Protein Chip Market Research And Analysis By End-Use, 2023-2031 ($ Million)
• 23. Asia-Pacific Protein Chip Market Research And Analysis By Country, 2023-2031 ($ Million)
• 24. Asia-Pacific Protein Chip Market Research And Analysis By Type, 2023-2031 ($ Million)
• 25. Asia-Pacific Protein Chip Market Research And Analysis By Application, 2023-2031 ($ Million)
• 26. Asia-Pacific Protein Chip Market Research And Analysis By End-Use, 2023-2031 ($ Million)
• 27. Rest Of The World Protein Chip Market Research And Analysis By Region, 2023-2031 ($ Million)
• 28. Rest Of The World Protein Chip Market Research And Analysis By Type, 2023-2031 ($ Million)
• 29. Rest Of The World Protein Chip Market Research And Analysis By Application, 2023-2031 ($ Million)
• 30. Rest Of The World Protein Chip Market Research And Analysis By End-Use, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Protein Chip Market Share By Type, 2023 Vs 2031 (%)
• 2. Global Analytical Microarrays Protein Chip Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Functional Protein Microarrays Protein Chip Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Reverse Phase Protein Microarrays Protein Chip Market Share By Region, 2023 Vs 2031 (%)
• 5. Global Protein Chip Market Share By Application, 2023 Vs 2031 (%)
• 6. Global Protein Chip For Antibody Characterization Market Share By Region, 2023 Vs 2031 (%)
• 7. Global Protein Chip For Clinical Diagnostics Market Share By Region, 2023 Vs 2031 (%)
• 8. Global Protein Chip For Proteomics Market Share By Region, 2023 Vs 2031 (%)
• 9. Global Protein Chip Market Share By End-Use, 2023 Vs 2031 (%)
• 10. Global Protein Chip In Pharmaceutical & Biotechnology Companies Market Share By Region, 2023 Vs 2031 (%)
• 11. Global Protein Chip In Academic & Research Institutes Market Share By Region, 2023 Vs 2031 (%)
• 12. Global Protein Chip In Diagnostic Laboratories Market Share By Region, 2023 Vs 2031 (%)
• 13. Global Protein Chip In Hospitals & Clinics Market Share By Region, 2023 Vs 2031 (%)
• 14. Global Protein Chip Market Share By Region, 2023 Vs 2031 (%)
• 15. US Protein Chip Market Size, 2023-2031 ($ Million)
• 16. Canada Protein Chip Market Size, 2023-2031 ($ Million)
• 17. UK Protein Chip Market Size, 2023-2031 ($ Million)
• 18. France Protein Chip Market Size, 2023-2031 ($ Million)
• 19. Germany Protein Chip Market Size, 2023-2031 ($ Million)
• 20. Italy Protein Chip Market Size, 2023-2031 ($ Million)
• 21. Spain Protein Chip Market Size, 2023-2031 ($ Million)
• 22. Rest Of Europe Protein Chip Market Size, 2023-2031 ($ Million)
• 23. India Protein Chip Market Size, 2023-2031 ($ Million)
• 24. China Protein Chip Market Size, 2023-2031 ($ Million)
• 25. Japan Protein Chip Market Size, 2023-2031 ($ Million)
• 26. South Korea Protein Chip Market Size, 2023-2031 ($ Million)
• 27. Rest Of Asia-Pacific Protein Chip Market Size, 2023-2031 ($ Million)
• 28. Latin America Protein Chip Market Size, 2023-2031 ($ Million)
• 29. Middle East And Africa Protein Chip Market Size, 2023-2031 ($ Million)

Protein Chip Market Size, Share & Trends Analysis Report by Type (Analytical Microarrays, Functional Protein Microarrays, and Reverse Phase Protein Microarrays), by Application (Antibody Characterization, Clinical Diagnostics, and Proteomics), and by End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories and Hospitals & Clinics), Forecast Period (2024-2031)

Protein chip market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). A protein chip, also known as a protein microarray, is a high-throughput technology used in proteomics for the parallel detection and quantification of multiple proteins in a single experiment. It consists of a solid surface, typically a glass slide or a silicon chip, onto which specific capture molecules such as antibodies, peptides, or proteins are immobilized in an array format. Major factors supporting the protein microarray market growth are the increasing demand for personalized medicine and precision diagnostics, technological investments, and innovations.

Market Dynamics

Advancements in Protein Chip Technology: Revolutionizing Proteomics and Diagnostics

Technological advancements in protein chip technology have revolutionized the field of proteomics research and clinical diagnostics. These advancements encompass improvements in microarray fabrication, surface chemistry, and detection methods, leading to enhanced sensitivity, specificity, and multiplexing capabilities of protein chips. Advanced protein chip platforms enable the simultaneous analysis of thousands of proteins from complex biological samples, facilitating biomarker discovery, drug target identification, and pathway analysis with unprecedented speed and accuracy. These technological innovations drive the development of novel protein chip assays tailored for various research and clinical applications, fueling the growth of the global protein chip market. For instance, in December 2023, Theralink Technologies announced groundbreaking research conducted in collaboration with George Mason University and the University of California, San Francisco. Through the ISPY-2 trial, tumors from over 700 breast cancer patients were evaluated using Reverse Phase Protein Array (RPPA), uncovering novel therapeutic avenues for challenging breast cancers.

The Role of Protein Chips in Personalized Healthcare

Growing demand for personalized medicine is a significant driver shaping the trajectory of the global protein chip market. Personalized medicine aims to provide tailored therapeutic interventions based on individual patient characteristics, including genetic makeup, proteomic profile, and environmental factors. Protein chips play a crucial role in personalized medicine by enabling the identification of disease biomarkers, molecular signatures, and treatment responses at the molecular level. By analyzing protein expression patterns and signaling pathways in patient samples, protein chips empower clinicians to make informed decisions regarding patient care, treatment selection, and disease management strategies. As personalized medicine gains prominence in healthcare, the demand for protein chips as essential tools for molecular profiling and precision diagnostics continues to grow, driving market expansion and diversification of product offerings.

Market Segmentation

• Based on type, the market is segmented into analytical microarrays, functional protein microarrays, and reverse-phase protein microarrays.
• Based on application, the market is segmented into antibody characterization, clinical diagnostics, and proteomics.
• Based on end-use, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, diagnostic laboratories, and hospitals & clinics.

Functional Protein Microarrays is Projected to Emerge as the Largest Segment

The functional protein microarrays segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes its versatility and utility in high-throughput protein analysis. Functional protein microarrays enable the simultaneous screening of thousands of protein interactions, protein-protein binding events, enzyme activities, and post-translational modifications in a single experiment. This high-throughput capability accelerates the discovery of novel protein functions, biomarkers, drug targets, and therapeutic compounds, facilitating advancements in basic research, drug development, and clinical diagnostics.

Clinical Diagnostics Segment to Hold a Considerable Market Share

The clinical diagnostics segment holds a considerable market share due to its critical role in advancing personalized medicine and precision diagnostics. Protein chips are increasingly utilized in clinical settings for the rapid and accurate detection of various diseases, including cancer, cardiovascular disorders, infectious diseases, and neurological conditions. By analyzing protein expression patterns and identifying disease-specific biomarkers, protein chips enable clinicians to diagnose diseases at early stages, predict treatment responses, and monitor disease progression with high sensitivity and specificity. For instance, in November 2023, Octave Bioscience, Inc. secured a $10.0 million grant from The Michael J. Fox Foundation to develop a multi-analyte protein biomarker test for Parkinson's disease, aiming to improve disease assessment.

Regional Outlook

The global protein chip market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Empowering Precision Healthcare: Asia-Pacific's Rise in the Protein Chip Market

Asia-Pacific emerges as the fastest-growing market in the global protein chip sector due to several key drivers. The region's significant investments in healthcare infrastructure and research capabilities, propelled by economic expansion and government initiatives, foster the adoption of advanced technologies like protein chips. With a large and diverse population, including many affected by chronic and infectious diseases, Asia-Pacific offers a substantial market for protein-based diagnostic solutions, fueling demand for protein chips. Moreover, the region's increasing focus on precision medicine and personalized healthcare, coupled with collaborations between local and international players, further propels market growth. For instance, in February 2023, Sengenics introduced KREXTM technology to address challenges in efficiently producing fully functional proteins for clinical diagnostics, vaccine development, and drug discovery. Utilizing Biotin Carboxyl Carrier Protein (BCCP), this innovation enhances protein folding and solubility, enabling high-throughput expression of correctly folded proteins. Technology facilitates the simultaneous evaluation of numerous mutant proteins, offering insights into potential therapeutic interventions.

North America Holds Major Market Share

Among all the regions, North America holds a significant share due to its robust healthcare infrastructure, research ecosystem, and leading pharmaceutical companies drive substantial demand for protein chips in applications like drug discovery and personalized medicine. Additionally, the region's emphasis on healthcare innovation and technological advancement, coupled with favorable government initiatives and funding support, further propels the market growth. With a large patient population, particularly those with chronic diseases, North America presents significant opportunities for protein-based diagnostic solutions. For instance, in January 2024, Agilent Technologies unveiled the ProteoAnalyzer system, an innovative automated parallel capillary electrophoresis system designed for protein analysis. This platform enhances efficiency and simplifies the analysis of complex protein mixtures, benefiting various sectors including pharmaceuticals, biotechnology, and academic research.

Market Players Outlook

The major companies serving the global protein chip market include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., and Randox Laboratories Ltd., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in January 2022, Illumina collaborated with SomaLogic to integrate the SomaScan Proteomics Assay into Illumina's high-throughput next-generation sequencing (NGS) platforms. This partnership aims to cater to the rapidly expanding high-throughput proteomics market, facilitating significant scientific discoveries within the research community.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Agilent Technologies, Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Bio-Rad Laboratories, Inc.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Thermo Fisher Scientific Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Protein Chip Market by Type
  • 4.1.1. Analytical Microarrays
  • 4.1.2. Functional Protein Microarrays
  • 4.1.3. Reverse Phase Protein Microarrays
• 4.2. Global Protein Chip Market by Application
  • 4.2.1. Antibody Characterization
  • 4.2.2. Clinical Diagnostics
  • 4.2.3. Proteomics
• 4.3. Global Protein Chip Market by End-Use
  • 4.3.1. Pharmaceutical & Biotechnology Companies
  • 4.3.2. Academic & Research Institutes
  • 4.3.3. Diagnostic Laboratories
  • 4.3.4. Hospitals & Clinics

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. Arrayit Corporation
• 6.2. Biotech Support Group
• 6.3. Bruker
• 6.4. CapitalBio Technology Co, Ltd.
• 6.5. CDI Laboratories Inc.
• 6.6. Full Moon BioSystems Inc.
• 6.7. GE Healthcare
• 6.8. Gyros Protein Technologies
• 6.9. HORIBA, Ltd.
• 6.10. Illumina Inc.
• 6.11. Innopsys Inc.
• 6.12. Merck KGaA
• 6.13. OriGene Technologies Inc.
• 6.14. PerkinElmer
• 6.15. Randox Laboratories Ltd.
• 6.16. RayBiotech, Inc.
• 6.17. Sengenics Corporation LLC
• 6.18. Shimadzu Scientific Instruments
• 6.19. Surmodics Inc.